下一个

自动播放

Minimum Residual Disease in Acute Lymphoblastic Leukemia

5 意见 • 08/04/23
分享
嵌入
administrator
administrator
订户
0

In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放